Restricted accessResearch articleFirst published online 2000-10
Medication Bezoar with Extended-Release Nifedipine/Biliary Cirrhosis Caused by Erythromycin/Four Cases of Lactic Acidosis and Hepatic Steatosis Associated with Stavudine Therapy/Acute Myelopathy following Heroin Insufflation/Increased Lithium Concentrations with a “Safe” NSAID/Drug-Induced Stroke and Complications of Intravesical Bacillus Calmette-Guerin
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's medWatch program (1-800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
Get full access to this article
View all access options for this article.
References
1.
NiezabitowskiL.M., NguyenB.N., GumsJ.G.Extende-release nifedipine bezoar identified one year after discontinuation. Ann Pharmacother.2000; 34: 862–4.
MillerK.D.Lactic acidosis and hepatic steatosis associated with use of stavudine: Report of four cases. Ann Intern Med.2000; 133: 192–6.
4.
McCrearyM.Acute myelopathy following intranasal insufflation of heroin; A case report. Neurology.2000; 55: 316–7.
5.
JonesM.T., StonerS.C.Increased lithium concentrations reported in patients treated with sulindac [letter]. J Clin Psychiatry.2000; 61: 527–8.
6.
PritchardJ., SandercockP.A.G.Drug-induced stroke. Adverse Drug Reaction Bulletin.2000; 202: 771–4.
7.
KonetyB.R.Complications of intravesical bacillus Calmette-Guerin. AUA News [publication of the American Urological Association].2000; 5(5): 1, 3,28,35.
